Arbutus Biopharma Corp ( ABUS) - Stock Earnings
ABUS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 5, 2026, midnight | — / — | — | — / — | — |
ABUS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -7.7 million USD | 529000 USD |
| 2025Q4 | -3.8 million USD | 1.1 million USD |
| 2026Q1 | 169.7 million USD | 179.1 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ABUS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -72.8 million USD | 18.1 million USD |
| 2024 | -69.9 million USD | 6.2 million USD |
| 2025 | -33.5 million USD | 14.1 million USD |
| 2026 Est. | — | — |
ABUS
Price: $4.38
Earnings Per Share: 0.83 USD
P/E Ratio: 4.99
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 545700
Ebitda: -10.9 millionMarket Capitalization: 962.0 million